22nd Century EBITDA 2011-2025 | XXII
22nd Century ebitda from 2011 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
|
22nd Century Annual EBITDA (Millions of US $) |
|
|---|---|
| 2024 | $-13 |
| 2023 | $-40 |
| 2022 | $-29 |
| 2021 | $-27 |
| 2020 | $-18 |
| 2019 | $-22 |
| 2018 | $-23 |
| 2017 | $-12 |
| 2016 | $-11 |
| 2015 | $-11 |
| 2014 | $-11 |
| 2013 | $2 |
| 2012 | $-2 |
| 2011 | $-4 |
| 2010 | $-1 |
|
22nd Century Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2025-06-30 | $-3 |
| 2025-03-31 | $-2 |
| 2024-12-31 | $-4 |
| 2024-09-30 | $-3 |
| 2024-06-30 | $-2 |
| 2024-03-31 | $-4 |
| 2023-12-31 | $-14 |
| 2023-09-30 | $-7 |
| 2023-06-30 | $-11 |
| 2023-03-31 | $-9 |
| 2022-12-31 | $1 |
| 2022-09-30 | $-14 |
| 2022-06-30 | $-9 |
| 2022-03-31 | $-8 |
| 2021-12-31 | $-9 |
| 2021-09-30 | $-7 |
| 2021-06-30 | $-6 |
| 2021-03-31 | $-5 |
| 2020-12-31 | $-6 |
| 2020-09-30 | $-4 |
| 2020-06-30 | $-4 |
| 2020-03-31 | $-4 |
| 2019-12-31 | $-5 |
| 2019-09-30 | $-7 |
| 2019-06-30 | $-5 |
| 2019-03-31 | $-5 |
| 2018-12-31 | $-5 |
| 2018-09-30 | $-6 |
| 2018-06-30 | $-7 |
| 2018-03-31 | $-5 |
| 2017-12-31 | $-4 |
| 2017-09-30 | $-3 |
| 2017-06-30 | $-3 |
| 2017-03-31 | $-3 |
| 2016-12-31 | $-3 |
| 2016-09-30 | $-2 |
| 2016-06-30 | $-3 |
| 2016-03-31 | $-3 |
| 2015-12-31 | $-3 |
| 2015-09-30 | $-3 |
| 2015-06-30 | $-2 |
| 2015-03-31 | $-4 |
| 2014-12-31 | $-6 |
| 2014-09-30 | $-3 |
| 2014-06-30 | $-2 |
| 2014-03-31 | $-1 |
| 2013-12-31 | $6 |
| 2013-09-30 | $-1 |
| 2013-06-30 | $-2 |
| 2013-03-31 | $-1 |
| 2012-12-31 | $0 |
| 2012-09-30 | $0 |
| 2012-06-30 | $-1 |
| 2012-03-31 | $0 |
| 2011-12-31 | $-1 |
| 2011-09-30 | $-1 |
| 2011-06-30 | $-1 |
| 2011-03-31 | $-1 |
| 2010-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Consumer Staples | Tobacco Products | $0.007B | $0.024B |
| 22nd Century Group, Inc. is a plant biotechnology company focused on decreasing/increasing the level of nicotine in the tobacco plant through genetic engineering and breeding. The Company is focused on development of smoking cessation aid and owns and controls several patents. The company's products include X-22, a prescription smoking cessation aid, which is a tobacco-based botanical medical product for use as a smoking cessation therapy. 22nd Century Group, Inc. is based in Williamsville, New York. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Philip Morris (PM) | United States | $241.512B | 21.00 |
| British American Tobacco (BTI) | United Kingdom | $111.750B | 0.00 |
| Altria (MO) | United States | $97.044B | 10.69 |
| JAPAN TOB (JAPAY) | Japan | $64.702B | 20.02 |
| Imperial Tobacco Group (IMBBY) | United Kingdom | $33.800B | 0.00 |
| Turning Point Brands (TPB) | United States | $1.868B | 30.24 |
| Universal (UVV) | United States | $1.319B | 10.78 |
| Ispire Technology (ISPR) | United States | $0.110B | 0.00 |
| Charlie's Holdings (CHUC) | United States | $0.054B | 20.00 |